The information published on Ibruxen.com is intended for general educational and informational purposes.
Not individualized medical advice
Website information does not diagnose a disease, determine an individual’s treatment or provide an individualized prescription.
Prescription medicine
Ibrutinib is a prescription anticancer medicine. Treatment should be initiated and supervised by an appropriately qualified healthcare professional.
Do not change treatment based on this website
Readers should not independently start, stop, increase, decrease or otherwise modify prescribed treatment based solely on information published on this website.
Regulatory differences
Approved indications, dosage instructions, formulations and warnings can vary between countries. Readers should consult the applicable local prescribing information.
Emergencies
Urgent symptoms should be evaluated by an appropriate healthcare professional or emergency service rather than through website communication.
Information changes
Medical evidence, product labeling and regulatory requirements can change. Information on this website may therefore require updating.
No doctor-patient relationship
Using this website does not establish a doctor-patient relationship.
Product information
Product-specific claims should be supported by manufacturer or regulatory documentation. Where information cannot be adequately established, it should be identified as requiring verification.